Synthesis and characterization of novel cycloalkanespiro-5-hydantoin phosphonic acids

Phosphorus, Sulfur and Silicon and the Related Elements

Volumn 185, Issue 7, 2010, Pages 1315-1320

  Naydenova, Emilia D ^a   Todorov, Petar T ^a   Troev, Kolio D ^b  

^a UNIVERSITY OF CHEMICAL TECHNOLOGY AND METALLURGY   (Bulgaria)

^b INSTITUTE OF POLYMERS   (Bulgaria)

Author keywords

Aminophosphonic acids; cycloalkanespiro 5 hydantoins; phosphorus trichloride

Indexed keywords

EID: 77954358619     PISSN: 10426507     EISSN: 15635325     Source Type: Journal    
DOI: 10.1080/10426501003751254     Document Type: Article

References (33)

1. K. D. Troev, Chemistry and Application of H-Phosphonates (Elsevier, Amsterdam 2006)
2. (b) P. Kafarski and B. Lejczak, Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity (Wiley, New York, 2000), p. 407.
3. E. W. Logusch, D. M. Walker, J. F. McDonald, J. E. Franz, J. J. Villafranca, C. L. Dilanni, J. A. Colanduoni, B. Li, and J. B. Shineller, Biochemistry, 29, 366 (1990).
4. T. D. Meek and J. J. Villiafranca, Biochemistry, 19, 5513 (1980).
5. J. Oleksyszyn, B. Boduszek, Ch. M. Kam, and J. C. Powers, J. Med. Chem., 37, 226 (1994).
6. W.W. Smith and P. A. Bartlett, J. Am. Chem. Soc., 120, 4622 (1998) and references cited therein.
7. J. W. Goding, Monoclonal Antibodies: Principles and Practice (Academic Press, New York, 1986).
8. M. Kabachnik and T. Medved, Dokl. Acad. Nauk SSSR, 83, 689 (1952).
9. E. K. Fields, J. Am. Chem. Soc., 74, 1528 (1952).
10. I. A. Natchev, Liebigs. Ann. Chem., 9, 861 (1988).
11. K. Troev, Phosphorus, Sulfur, and Silicon, 127, 167 (1997)
12. (b) K. Troev, Sh. Cremer, and G. Haegele, Heteroatom Chem., 10, 627 (1999)
13. (c) E. Naydenova, K. Troev,M. Topashka-Ancheva, G. Haegele, I. Ivanov, and A. Kril, Amino Acids, 33, 695 (2007).
14. P. P. Giannousis and P. A. Bartlett, J. Med. Chem., 30, 1603 (1987).
15. J. Huang and R. Chen, Heteroatom Chem., 11, 480 (2000).
16. E. Naydenova, M. Topashka-Ancheva, P. Todorov, Ts. Yordanova, and K. Troev, Bioorg. Med. Chem., 14, 2190 (2006).
17. P. Todorov, E. Naydenova, R. Petrova, B. Shivachev, and K. Troev, Acta Crystallogr. Sect. C, 62, o661 (2006).
18. N. Rabasso, N. Louaisil, and A. Fadel, Tetrahedron, 62, 7445 (2006)
19. (b) N. Louaisil, N. Rabasso, and A. Fadel, Synthesis, 289 (2007).
20. E. Naydenova, P. Todorov,M. Topashka-Ancheva,G.Momekov, Ts.Yordanova, S.Konstantinov, and K. Troev, Eur. J. Med. Chem., 43, 1199 (2008).
21. N. A.Meanwell, H. R. Roth, E. C. R. Smith, D. L. Wedding, and J. J. K. Wright, J. Org. Chem., 56, 6897 (1991).
22. R. Sarges and P. J. Oates, Prog. Drug. Res., 40, 99 (1993).
23. P. Barraclough, M. L. Bolofo, H. Giles, J. Gillam, C. J. Harris, M. G. Kelly, P. Leff, A. McNeill, A. D. Robertson, R. J. Stepney, and B. J. R. Whittle, Bioorg. Med. Chem., 4, 81 (1996).
24. F. L. Wessels, T. J. Schawn, and S. F. Pong, J. Pharm. Sci., 69, 1102 (1980).
25. A. A. El-Barbarly, A. I. Khodair, E. B. Pedersen, and C. Nielsen, J. Med. Chem., 37, 73 (1994).
26. W. M. Cloyd, S. W. Lynn, K. Ramsey, and S. Baron, Virology, 173, 581 (1989).
27. M. L. Brown, G. B. Brown, and W. J. Brouillette, J. Med. Chem., 40, 602 (1997).
28. (a)M. Engelmann and J. Pikl, U.S. Pat. 2,304,156 (1942)
29. (b) J. Pikl, U.S. Pat. 2,328,358 (1943).
30. H. Bucherer and V. Lieb, J. Prakt. Chem., 141, 5 (1934).
31. J. Rubido, C. Pedregal, M. Espada, and J. Elguero, Synthesis, 3, 307 (1985)
32. (b) E. Ware, Chem. Reviews, 46, 403 (1950).
33. E. Naydenova, N. Pencheva, J. Popova, N. Stoyanov, M. Lazarova, and B. Aleksiev, Il Farmaco, 57, 189 (2002).